Skip to main content

New breast cancer targets

May. 4, 2018, 8:00 AM

Genome-wide association studies (GWAS) have identified more than 150 genetic variations associated with increased risk for breast cancer. Most of these variants are not located in protein-coding gene regions but are assumed to regulate the expression of certain genes.

One way to figure out what these variants are doing is to conduct a cis-eQTL analysis. That’s a way of detecting changes in the expression of genes presumably regulated by a nearby variant.

Using four large-scale data sets from normal and cancerous breast tissue samples, Xingyi Guo, PhD, and colleagues identified 101 candidate breast cancer susceptibility genes with variant-associated gene expression changes. In breast cancer cells grown in culture, the researchers also demonstrated how three genes promoted tumor growth by disrupting normal cell behavior.

Their findings, published May 3 in the American Journal of Human Genetics, reveal potential target genes associated with an increased risk of breast cancer and provide additional insights into the underlying genetic and biological mechanisms that drive this common cancer.

This research was supported in part by research development funds from Vanderbilt University Medical Center and grants from the National Institutes of Health (CA148667) and the National Natural Science Foundation of China.

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to aliquots@vanderbilt.edu

Recent Stories from VUMC News and Communications Publications

Brighter days ahead

Vanderbilt Medicine

Brighter days ahead

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

Combating cancer disparities is an out-of-office assignment

Momentum

Combating cancer disparities is an out-of-office assignment

more